HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $55 | -29.5% | 36,624 | +17.3% | 0.00% | -100.0% |
| Q4 2022 | $78 | -100.0% | 31,224 | -19.4% | 0.00% | 0.0% |
| Q3 2022 | $163,000 | +270.5% | 38,719 | +148.3% | 0.00% | – |
| Q2 2022 | $44,000 | -61.4% | 15,596 | -22.1% | 0.00% | -100.0% |
| Q1 2022 | $114,000 | -32.1% | 20,017 | +8.5% | 0.00% | 0.0% |
| Q4 2021 | $168,000 | +12.8% | 18,443 | +31.9% | 0.00% | 0.0% |
| Q3 2021 | $149,000 | -15.3% | 13,983 | +23.0% | 0.00% | 0.0% |
| Q2 2021 | $176,000 | -27.0% | 11,366 | +49.2% | 0.00% | -50.0% |
| Q3 2018 | $241,000 | -47.5% | 7,616 | -35.5% | 0.00% | -33.3% |
| Q2 2018 | $459,000 | +30.0% | 11,813 | -7.7% | 0.00% | +50.0% |
| Q1 2018 | $353,000 | +29.8% | 12,798 | -15.0% | 0.00% | 0.0% |
| Q4 2017 | $272,000 | +262.7% | 15,053 | +263.8% | 0.00% | +100.0% |
| Q2 2016 | $75,000 | +2.7% | 4,138 | +8.1% | 0.00% | – |
| Q1 2016 | $73,000 | +1.4% | 3,827 | +41.1% | 0.00% | -100.0% |
| Q4 2015 | $72,000 | – | 2,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |